What is Stefan K.L. Oh’s direct AHR share ownership after these transactions?

Following the vesting, conversion, and tax withholding, Stefan K.L. Oh directly holds 88,438 shares of American Healthcare REIT common stock. This figure reflects his updated ownership after receiving the vested PRSU shares and having a portion withheld by the company to cover associated tax liabilities.

CIO at American Healthcare REIT (NYSE: AHR) receives PRSU stock

Filing Impact

(Neutral)

Filing Sentiment

(Neutral)

Form Type

Rhea-AI Filing Summary

American Healthcare REIT, Inc. Chief Investment Officer Stefan K.L. Oh received a performance-based restricted stock unit (PRSU) award that vested into 6,370 shares of common stock on March 12, 2026. Each unit converted into one share of common stock under the company’s incentive plan.

To cover related tax obligations, 3,437 shares of common stock were withheld by the company at a price of $52.80 per share. After these compensation-related transactions and tax withholding, Oh directly holds 88,438 shares of common stock, reflecting a net increase in his equity stake.

Insider Trade Summary

Net Buyer: 2,933 shares

Net Buy 4 txns

Insider Oh Stefan K.L.

Role Chief Investment Officer

Type	Security	Shares	Price	Value
Grant/Award	Restricted Stock Unit	6,370	$0.00	$0.00
Exercise	Restricted Stock Unit	6,370	$0.00	$0.00
Exercise	Common Stock	6,370	$0.00	$0.00
Exercise Price or Tax Liability	Common Stock	3,437	$52.80	$181K

Holdings After Transaction: Restricted Stock Unit — 0 shares (Direct); Common Stock — 88,438 shares (Direct)

Footnotes (3)

F1. Each restricted stock unit converts into one share of the Issuer's common stock.
F2. Shares withheld by the Issuer to satisfy the Reporting Person's tax obligations associated with the vesting of performance-based restricted stock units ("PRSUs") on March 12, 2026.
F3. These PRSUs were granted without cash consideration on April 3, 2023 under the Issuer's Second Amended and Restated 2015 Incentive Plan. The performance goals of such PRSUs were confirmed as having been met on March 12, 2026, on which date such PRSUs vested in full.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google

Form 4 Insider Transactions: What Each Field Means →

Accepted by SEC EDGAR 03/16/2026 - 04:30 PM

FAQ

What did AHR executive Stefan K.L. Oh report in this Form 4?

Stefan K.L. Oh reported vesting of performance-based restricted stock units converting into shares of American Healthcare REIT common stock. The filing also shows shares withheld by the company to satisfy his tax obligations, resulting in an updated direct ownership position after these compensation-related entries.

How many PRSU shares vested for AHR’s Chief Investment Officer?

A total of 6,370 performance-based restricted stock units vested for the Chief Investment Officer, each converting into one share of American Healthcare REIT common stock. These units were originally granted under the company’s Second Amended and Restated 2015 Incentive Plan without cash consideration as part of executive compensation.

How many AHR shares were withheld for taxes and at what price?

The company withheld 3,437 shares of American Healthcare REIT common stock to satisfy Stefan K.L. Oh’s tax obligations. These shares were valued at $52.80 per share, reflecting a non-market tax-withholding disposition rather than an open-market sale, tied directly to the vesting of performance-based restricted stock units.

Were the AHR PRSUs granted for cash consideration?

The performance-based restricted stock units were granted without cash consideration under American Healthcare REIT’s Second Amended and Restated 2015 Incentive Plan. They represent a form of equity-based executive compensation, with performance goals confirmed as met on March 12, 2026, when the units vested in full.

What triggered the vesting of AHR’s performance-based restricted stock units?

Vesting was triggered when performance goals tied to the PRSUs were confirmed as having been met on March 12, 2026. On that date, the performance-based restricted stock units vested in full and converted into an equal number of shares of American Healthcare REIT common stock for the executive.

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Oh Stefan K.L.

(Last)

(First)

(Middle)

18191 VON KARMAN AVENUE

THIRD FLOOR

(Street)

IRVINE

92612

(City)

(State)

(Zip)

2. Issuer Name and Ticker or Trading Symbol
American Healthcare REIT, Inc. [ AHR ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director	10% Owner
X	Officer (give title below)	Other (specify below)
	Chief Investment Officer

3. Date of Earliest Transaction (Month/Day/Year)
03/12/2026

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	Code	V	Amount	(A) or (D)	Price		6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
Common Stock	03/12/2026		M		6,370	A	⁽¹⁾	91,875	D
Common Stock	03/12/2026		F		3,437⁽²⁾	D	$52.8	88,438	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares	8. Price of Derivative Security (Instr. 5)		10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
Restricted Stock Unit	⁽¹⁾	03/12/2026		A		6,370		⁽³⁾	⁽³⁾	Common Stock	6,370	$0	6,370	D
Restricted Stock Unit	⁽¹⁾	03/12/2026		M			6,370	⁽³⁾	⁽³⁾	Common Stock	6,370	$0	0	D

Explanation of Responses:

1. Each restricted stock unit converts into one share of the Issuer's common stock.

2. Shares withheld by the Issuer to satisfy the Reporting Person's tax obligations associated with the vesting of performance-based restricted stock units ("PRSUs") on March 12, 2026.

3. These PRSUs were granted without cash consideration on April 3, 2023 under the Issuer's Second Amended and Restated 2015 Incentive Plan. The performance goals of such PRSUs were confirmed as having been met on March 12, 2026, on which date such PRSUs vested in full.

	/s/ STEFAN K.L. OH	03/16/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

Source: View Original Filing on SEC EDGAR